Reactive arthritis in a patient after covid-19 infection: a case report and review of the literature

Autori

Cuvinte cheie:

reactive arthritis, COVID-19 infection

Rezumat

Reactive arthritis in a patient after COVID-19 infection: a case report and review of the literature COVID-19 infection can lead to a wide variety of complications involving the majority of body systems, including the musculoskeletal one. One of its clinical manifestations of it is reactive arthritis. In the following, we present the clinical case of a 56-year-old woman with post-COVID-19 reactive arthritis and it’s follow-up.

Referințe

1. Ahmed S, Padhan P, Misra R, Danda D. Update on poststreptococcal reactive arthritis: narrative review of a forgotten disease. Curr Rheumatol Rep. 2021;23:19. https://doi.org/10.1007/s11926-021-00982-3

2. Ahmed S, Zimba O, Gasparyan AY. COVID-19 and the clinical course of rheumatic manifestations. Clin Rheumatol. 2021; 40:2611-2619. https://doi.org/10.1007/s10067-021-05691-x

3. Angileri F, Legare S, Marino Gammazza A, Conway de Macario E, JL Macario A, Cappello F. Molecular mimicry may explain multi-organ damage in COVID-19. Autoimmun Rev. 2020; 19:102591. https://doi.org/10.1016/j.autrev.2020.102591

4. Antonio I-G, Jose FR, Rafael V, Eric LM. A brief history of Stoll-Brodie-Fiessinger-Leroy syndrome (Reiters syndrome) and reactive arthritis with a translation of Reiters original 1916 article into English. Curr Rheumatol Rev. 2004;1:71-79 https://doi.org/10.2174/1573397052954190

5. Baimukhamedov C, Barskova T, Matucci-Cerinic M. Arthritis after SARS-CoV-2 infection. Lancet Rheumatol. 2021; 3:e324-e325. https://doi.org/10.1016/S2665-9913(21)00067-9

6. Bekaryssova, D., Yessirkepov, M., Zimba, O., Gasparyan, A. Y., & Ahmed, S. (2022). Reactive arthritis before and after the onset of the COVID-19 pandemic. Clinical rheumatology, 1-12. Advance online publication. https://doi.org/10.1007/s10067-022-06120-3

7. Birra D, Benucci M, Landolfi L, et al. . COVID 19: a clue from innate immunity. Immunol Res 2020;68:161-8, https://doi.org/10.1007/s12026-020-09137-5

8. Bonelli M, Dalwigk K, Platzer A, et al. IRF1 is critical for the TNF-driven interferon response in rheumatoid fibroblast-like synoviocytes. Exp Mol Med. 2019; 51:1-11. https://doi.org/10.1038/s12276-019-0267-6

9. Cappello F. Is COVID-19 a proteiform disease inducing also molecular mimicry phenomena? Cell Stress Chaperones. 2020;25:381-382 https://doi.org/10.1007/s12192-020-01112-1

10. Carter JD, Hudson AP. Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin North Am 2009;35:21-44 https://doi.org/10.1016/j.rdc.2009.03.010

11. Cincinelli G, Di Taranto R, Orsini F, et al. A case report of monoarthritis in a COVID-19 patient and literature review: simple actions for complex times. Medicine (Baltimore) 2021;100:e26089 https://doi.org/10.1097/MD.0000000000026089

12. Coath, F. L., Mackay, J., & Gaffney, J. K. (2021). Axial presentation of reactive arthritis secondary to COVID-19 infection. Rheumatology (Oxford, England), 60(7), e232-e233 https://doi.org/10.1093/rheumatology/keab009

13. Colmegna I, Cuchacovich R, Espinoza LR. HLA-B27-associated reactive arthritis: pathogenetic and clinical considerations. Clin Microbiol Rev. 2004; 17:348-369. https://doi.org/10.1128/CMR.17.2.348-369.2004

14. Danssaert Z, Raum G, Hemtasilpa S.. Reactive arthritis in a 37-year-old female with SARS-CoV2 infection. Cureus 2020;12:e9698 https://doi.org/10.7759/cureus.9698

15. De Stefano L, Rossi S, Montecucco C, Bugatti S. Transient monoarthritis and psoriatic skin lesions following COVID-19. Ann Rheum Dis 2020; published on 4 Aug 2020.

16. Derksen VFAM, Kissel T, Lamers-Karnebeek FBG, et al (2021) Onset of rheumatoid arthritis after COVID-19: coincidence or connected? Ann Rheum Dis Annrheumdis 2021-219859. https://doi.org/10.1136/annrheumdis-2021-eular.1398

17. Di Carlo M, Tardella M, Salaffi F. Can SARS-CoV-2 induce reactive arthritis? Clin Exp Rheumatol. 2021;39(Suppl 128):25-26

18. Dotan A, Muller S, Kanduc D, et al. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev. 2021; 20:102792. https://doi.org/10.1016/j.autrev.2021.102792

19. García-Kutzbach A, Chacón-Súchite J, García-Ferrer H, Iraheta I. Reactive arthritis: update 2018. Clin Rheumatol. 2018; 37:869-874. https://doi.org/10.1007/s10067-018-4022-5

20. Gasparotto M, Framba V, Piovella C, et al. Post-COVID-19 arthritis: a case report and literature review. Clin Rheumatol. 2021;40:3357-3362 https://doi.org/10.1007/s10067-020-05550-1

21. Hannu T, Inman R, Granfors K, Leirisalo-Repo M. Reactive arthritis or post-infectious arthritis? Best Pract Res Clin Rheumatol. 2006; 20:419-433. https://doi.org/10.1016/j.berh.2006.02.003

22. Hayes KM, Hayes RJP, Turk MA, Pope JE. Evolving patterns of reactive arthritis. Clin Rheumatol. 2019; 38:2083-2088. https://doi.org/10.1007/s10067-019-04522-4

23. Hønge BL, Hermansen M-LF, Storgaard M. Reactive arthritis after COVID-19. BMJ Case Rep. 2021;14:e241375 https://doi.org/10.1136/bcr-2020-241375

24. Houshmand H, Abounoori M, Ghaemi R, et al (2020) Ten-year-old boy with atypical COVID-19 symptom presentation: a case report. Clin Case Rep [Online ahead of print]. https://doi.org/10.22541/au.160066996.61637020/v2

25. Jali I. Reactive arthritis after COVID-19 infection. Cureus. 2020;12:e11761 https://doi.org/10.7759/cureus.11761

26. Liew IY, Mak TM, Cui L, et al. A case of reactive arthritis secondary to coronavirus disease 2019 infection. J Clin Rheumatol. 2020; 26:233. https://doi.org/10.1097/RHU.0000000000001560

27. López-Medina C, Molto A, Sieper J, et al. Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study. RMD Open. 2021; 7:e001450. https://doi.org/10.1136/rmdopen-2020-001450

28. Metyas S, Chen C, Aung T, Ballester A, Cheav S. Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series. Curr Rheumatol Rev. 2022 Feb 11. Epub ahead of print. PMID: 35152867 https://doi.org/10.2174/1573397118666220211155716

29. Muyayalo KP, Huang DH, Zhao SJ, Xie T, Mor G, Liao AH. COVID-19 and Treg/Th17 imbalance: potential relationship to pregnancy outcomes. Am J Reprod Immunol 2020;84:e13304, https://doi.org/10.1111/aji.13304

30. Ono K, Kishimoto M, Shimasaki T, et al. Reactive arthritis after COVID-19 infection. RMD Open. 2020;6:e001350 https://doi.org/10.1136/rmdopen-2020-001350

31. Onofrio L, Caraglia M, Facchini G, Margherita V, De Placido S, Buonerba C. Toll-like receptors and COVID-19: a two-faced story with an exciting ending. Future Sci OA 2020;6:FSO605 https://doi.org/10.2144/fsoa-2020-0091

32. Pogreba-Brown K, Austhof E, Tang X, et al. Enteric pathogens and reactive arthritis: systematic review and meta-analyses of pathogen-associated reactive arthritis. Foodborne Pathog Dis. 2021;18:627-639 https://doi.org/10.1089/fpd.2020.2910

33. Poulas K, Farsalinos K, Zanidis C. Activation of TLR7 and innate immunity as an efficient method against COVID-19 pandemic: imiquimod as a potential therapy. Front Immunol 2020;11:1373. https://doi.org/10.3389/fimmu.2020.01373

34. Roongta R, Chattopadhyay A, Ghosh A (2021) Correspondence on "Onset of rheumatoid arthritis after COVID-19: coincidence or connected?" Ann Rheum Dis Annrheumdis 2021-220479.

35. Saricaoglu EM, Hasanoglu I, Guner R. The first reactive arthritis case associated with COVID-19. J Med Virol. 2021;93:192-193 https://doi.org/10.1002/jmv.26296

36. Schenker HM, Hagen M, Simon D, et al. Reactive arthritis and cutaneous vasculitis after SARS-CoV-2 infection. Rheumatology (Oxford) 2021;60:479-480 https://doi.org/10.1093/rheumatology/keaa689

37. Selmi C, Gershwin ME.. Diagnosis and classification of reactive arthritis. Autoimmun Rev 2014;13:546-9 https://doi.org/10.1016/j.autrev.2014.01.005

38. Sinaei R, Pezeshki S, Parvaresh S, et al. Post SARSCoV-2 infection reactive arthritis: a brief report of two pediatric cases. Pediatr Rheumatol Online J. 2021; 19:89. https://doi.org/10.1186/s12969-021-00555-9

39. Smatti MK, Cyprian FS, Nasrallah GK, et al. Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. 2019; 11:762. https://doi.org/10.3390/v11080762

40. Suhrbier A. Rheumatic manifestations of chikungunya: emerging concepts and interventions. Nat Rev Rheumatol. 2019; 15:597-611. doi: 10.1038/s41584-019-0276-9 https://doi.org/10.1038/s41584-019-0276-9

41. Taha SI, Samaan SF, Ibrahim RA, El-Sehsah EM, Youssef MK. Post-COVID-19 arthritis: is it hyperinflammation or autoimmunity? Eur Cytokine Netw. 2021 Dec 1;32(4):83-88. PMID: 35118946; PMCID: PMC8831681 https://doi.org/10.1684/ecn.2021.0471

42. Thomas KN, Anuja AK, Gupta L. Clinical profile of adults and children with reactive arthritis in India - A cohort study. Indian J Rheumatol. 2020; 15:304-309. https://doi.org/10.4103/injr.injr_126_20

43. Tuompo R, Lääveri T, Hannu T, et al. Reactive arthritis and other musculoskeletal symptoms associated with acquisition of diarrhoeagenic Escherichia coli (DEC) Ann Rheum Dis. 2020;79:605-611 https://doi.org/10.1136/annrheumdis-2019-216736

44. Wu D, Yang XO. TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib. J Microbiol Immunol Infect 2020;53:368-70. https://doi.org/10.1016/j.jmii.2020.03.005

Descărcări

Publicat

03.05.2026

Cum cităm

[1]
Sadovici-Bobeica, V. et al. 2026. Reactive arthritis in a patient after covid-19 infection: a case report and review of the literature. Sănătate Publică, Economie şi Management în Medicină. 2(93) (May 2026), 251–257.

Cele mai citite articole ale aceluiași autor(i)

Articole similare

1-10 of 136

Puteți, de asemenea, începeți o căutare avansată de similaritate pentru acest articol.